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Introduction
Supply of nutrients to the fetus is one of main functions of the placenta. Fetal development is dependent on placental nutrient supply, and insufficient nutrient supply increases the risk of fetal and perinatal diseases [1, 2] . We previously showed that the expression levels of transporters that provide folate to the fetus change with progress of gestation [3] . It is therefore important to reconsider the expression and function of nutrient supply systems throughout the period of gestation, from the early stage of pregnancy to the end of pregnancy. More than twenty transporters are expressed in the placenta and they control the concentrations of amino acids as they work coordinately [4] . Although it is known that there is a relationship between deficiency of amino acid transporters and fetal growth deficiencies such as intrauterine growth restriction (IUGR) [1] , the expression levels of amino acid transporters in each stage of gestation are unknown.
Glutamine is one of the components of protein, and it plays various roles in fetal growth and is therefore supplied into fetal circulation at the highest rate of all amino acids [5] .
Glutamine is involved in the citric acid cycle, biosynthesis of purines and pyrimidines, and ammonia metabolism in addition to protein synthesis. Furthermore, glutaminase produces glutamate from glutamine in many organs, and glutamate acts as a precursor of GABA, a neurotransmitter, and glutathione, an antioxidant component [6] . This transformation between glutamine and glutamate also has an essential role in the regulation of intracellular pH [7] . Since glutamine and glutamate are involved in many biosynthesis and metabolism processes, control of the concentrations of these amino acids between the placenta and fetus is essential. It has been reported that a large amount of glutamine is released from the placenta into fetal circulation and, reversely, glutamate is taken up by the placenta from fetal blood [8, 9] . This glutamate-glutamine cycle in the placenta may play a major role in this exchange to contribute to the regulation of concentrations of these amino acids.
Systemic glutamine deficiency is related to multisystem disease and fatal multiple organ failure [10] . Thus, the placenta produces a large amount of glutamine to keep up with fetal demand [9] . Glutamine is produced by glutamine synthetase in mammalian cells, and this is an essential step in ammonium metabolism in the liver and brain [11] . The developing brain is more susceptible than the brain in adulthood, and ammonia toxicity could cause irreversible damage to the central nervous system such as cortical atrophy [12] .
Production of glutamine by glutamine synthetase is directly associated with ammonia detoxification and it may decrease the risk of abnormal neurodevelopment. Cytotrophoblast cells, which are in contact with fetal circulation in the placenta, contain glutamine synthetase [13] . It is possible that cytotrophoblast cells play a key role in glutamine supply and ammonium metabolism in the placenta.
In mammalian organs, glutamine is transported via system A, system N, system y + L, ASCT2, B 0 AT, and system L [14] [15] [16] [17] . In the placenta, system A is well studied for its essential role in amino acid uptake at microvillous membrane and its relationship between IUGR [1, 18, 19] . System A belongs to the SLC38 family. On the other hand, little is known about the placental expression and function of system N, despite the fact that system N also belongs to the SLC38 family [20, 21] . SNAT3 has been reported to be expressed in the liver, brain and kidney. Moreover, its expression in the placenta has been discussed for a long time [18, 22] . SNAT3 mediates glutamine transport with sodium and proton coupled manner, and it contributes to ammonia metabolism in the liver and brain [23] [24] [25] .
Since glutamine is critical for fetal growth, it is important to clarify the expression of transporters that mediate glutamine transport in the placenta and their alteration during pregnancy. However, little is known about the expression of nutrient transporters in the early period of gestation or their expression in cytotrophoblast cells [26] . 
Materials and methods

Animals
Pregnant female Wistar rats were obtained from Slc (Hamamatsu, Japan). The rats were housed for at least 2 days before harvesting placentas. The experimental protocols were reviewed and approved by the Hokkaido University Animal Care Committee in accordance with the "Guide for the Care and Use of Laboratory Animals".
Tissue collection
Full-term placentas were obtained from women who had caesarean sections with healthy babies and no complications of pregnancy at Sapporo Maternity Womens' Hospital in Japan. Written of informed consent was obtained from the women, and this study was approved by the Ethics Committee of Hokkaido University.
Isolation and culture of human trophoblast cells
Cytotrophoblast cells were isolated immediately after collection of the placenta as described in previous reports [27] [28] [29] 10% of FBS and 1% of penicillin/streptomycin (Sigma Aldrich, MO)). The mixture was incubated at 37°C for 60 min with continuous round shaking at 120 rounds/min. After enzyme treatment, the tissue suspension was filtered with gauze and this procedure was once repeated for the leftover. The filtrate was centrifuged at 700 × g for 5 min, and the pellet was suspended with 10 ml of culture medium. The digested cells were put onto a 10-70% discontinuous percoll gradient (GE Healthcare Bio-sciences AB, Uppsala, Sweden) in a 50 ml centrifuge tube and centrifuged at 1500 × g for 15 min. The purified cytotrophoblast cells were carefully collected in the region corresponding to a density of 1.035-1.064 g/l [30] , and the percoll removing step was repeated. The cell pellet was suspended in 5 ml of medium and filterd with 30 µm MACS ® Pre-Separation Filters (Miltenyi Biotec K.K, Tokyo, Japan).
Finally, the cells were adjusted to 1.0 × 10 6 cells/ 1 ml in culture medium and incubated in 6-well culture plates (2 ml/well) at 37°C with 5% CO 2 and 95% humidity [31] .
Hormone and enzyme analysis
Isolated cytotrophoblast cells were cultivated for up to 4 days. The culture medium was collected and centrifuged. Human chorionic gonadotropin (hCG) in the supernatant of the culture medium was detected by using an ELISA kit (Cosmo Bio, Tokyo, Japan).
Real-time RT-PCR analysis
Total RNA was prepared from rat placenta, human placenta, and isolated human cytotrophoblast cells using an Isogen (Nippon Gene, Tokyo) and an RNase-Free DNase Set (Qiagen, Hilden, Germany). Single-strand cDNA was made from 0.5-2.0 µg of total RNA by reverse transcription (RT) using an Omniscript RT Kit. PCR was performed using Tfi DNA polymerase (QIAGEN) with each nutrient transporter and GAPDH-specific primers through 23-40 cycles of 94°C for 30 sec, 53-61°C for 30 sec and 72°C for 20 sec. The primers were designed on the basis of sequence data in the GenBankTM database. The sequences of the specific primers are shown in Table 1 . The PCR products were subjected to electrophoresis on a 2% agarose gel and then visualized by ethidium bromide staining.
Quantitative real-time PCR was performed using an ABI PRISM 7700 Sequence Detector (Applied Biosystems, Foster City, CA) with Platinum ® SYBR ® Green qPCR SuperMix-UDG (Invitrogen) as per the manufacturer's protocol. The PCR products were normalized to amplified GAPDH, the internal reference gene.
Western blot analysis
Total protein extracts were prepared from rat placenta and isolated human cytotrophoblast cells. Tissue and cells were suspended in lysis buffer containing 1.0%
Triton X-100, 0.1% SDS, and 4.5 M urea. The suspension was left to stand for 5 min and sonicated for 15 min at 4°C. Then it was centrifuged at 12,000 × g for 15 min at 4°C, and the protein concentration in the clear supernatant was determined by the method of Lowry [32] .
The samples were denatured at 100°C for 3 min in loading buffer containing 50 mM Tris-HCl, 2% SDS, 5% 2-mercaptoethanol, 10% glycerol, 0.002% BPB, and 3. was visualized by using a confocal microscope (Zeiss LSM-510; Carl Zeiss Inc., Thornwood, NY).
Statistical analyses
Comparisons between paired groups were performed using Student's t-test or Welch's t-test to determine the significance of differences. Bartlett's test and Friedman's test were performed against the relative alteration of SNAT3 expression in the isolated cytotrophoblast cells with their differentiation.
Results
Expression of glutamine transporters in the rat placenta
Expression of transporters that transport glutamine in the rat placenta was examined by RT-PCR. System A transporters were originally reported to be the main system for transporting glutamine in the placenta [18, 33] . We used them as a positive control, and we found that they were expressed on both 14 th and 20 th day of gestation (Figure 1a, 1b, 1c) . In 
Alteration of glutamine transporters during pregnancy
We then investigated alteration of the expression level of mRNA of each transporter in the placenta throughout the period of gestation using real-time RT-PCR. The expression levels of system A transporters (SNAT1, SNAT2 and SNAT4) (Figure 2a were also detected by real-time PCR (Figure 2g, 2h) . Although SNAT5 and SNAT6 were expressed throughout the period of gestation, significant alteration in their expression was not found at any stage of pregnancy. On the other hand, mRNA of SNAT3 was expressed at a high level in the placenta in the early period of pregnancy and its expression level decreased as gestation progressed (Figure 3a ) (p<0.05). Moreover, we determined the protein levels of SNAT3 in the rat placenta by Western blotting analysis. We found that SNAT3 was expressed at a high level in the early period of pregnancy and that its expression level was reduced as gestation progressed (Figure 3b ). This is the first study demonstrating that SNAT3 is expressed in the placenta.
Isolation of cytotrophoblast cells from term placenta
In order to determine whether SNAT3 is also expressed in human placenta, we investigated the expression pattern of SNAT3 by using cytotrophoblast cells from human term placenta. Isolated trophoblast cells were cultured for 4 days. On the first day of culture, cells were found to be mononuclear and positive for cytokeratin 7 by using immunostaining methods (Figure 4a ). On the third day of culture, cells were fused and differentiated as they formed multinucleated syncytiotrophoblast cells. The differentiation was confirmed by measurement of hCG secretion in the culture medium. The hCG level in the culture medium increased and peaked on the third day (Figure 4b ), and this pattern of hCG secretion agrees well with the results of a previous study [29] , reflecting the formation of syncytiotrophoblast cells [31] . These results showed that we successfully isolated cytotrophoblast cells and differentiated into syncytiotrophoblast cells.
Expression of SNAT3 in the human placenta
We then investigated the relationship between expression of SNAT3 and differentiation of cytotrophoblast cells. SNAT3 was expressed in the isolated cytotrophoblast cells, and the expression level of SNAT3 decreased significantly as differentiation of cytotrophoblast cells progressed (Figure 5a -5b, p<0.05). SNAT3 expression had almost disappeared on day 3 of culture.
Discussion
Fetal development is dependent on nutrient supply from the placenta. Most of the nutrients are provided from maternal blood, while some of them are produced in the placenta.
Since the fetus needs a large amount of glutamine from the early period of gestation, systemic glutamine deficiency leads to fatal neonatal multiple organ failure. Thus, we focused on the transporters that contribute to the provision of glutamine.
This study suggested that the expression levels of some glutamine transporters change during pregnancy, and its regulation is different. Most of the transporters are up-regulated as gestation progresses. System A and system y + L are expressed at high levels in the placenta in the late stage of gestation. These results tend to be consistent with the previous studies [26, 34, 35] . Moreover, it has been reported that system A plays a key role in glutamine transport from the maternal side into placental cells [18, 33] . Therefore, increased level of system A mRNA contributes to uptake of a large amount of glutamine from maternal circulation in the late period of gestation. On the other hand, the expression level of SNAT3, the system N transporter, decreases as gestation progresses. SNAT3 is expressed at a high level in the rat placenta in the early stage of pregnancy. We isolated cytotrophoblast cells from human term placentas and cultured them to clarify whether SNAT3 is expressed in human placental cells, and we found that expression levels of SNAT3 are higher in cytotrophoblast cells than in syncytiotrophoblast cells (Supplemental Figure 1) . It has been reported that the expression of SNAT3 was not detected in term placenta and that the transport of glutamine via SNAT3 was not detected either in term placenta or by BBMV uptake study [18, 33] . It is possible that it was difficult to detect SNAT3 because it is expressed in the early stage of pregnancy or in cytotrophoblast cells. This finding that SNAT3 is expressed in the early period of gestation indicates the importance for understanding the nutrient supply system throughout gestation. The concentrations of glutamine in fetal circulation in mid gestation and late gestation are not different [5] .
Therefore, there are some other systems to supply glutamine to the fetus in the early period of gestation instead of system A, the expression level of which is low at this time. Our results showed that there are the differences between system A and SNAT3 despite the fact that they belong to the same SLC family. System A is expressed at high levels in the late period of gestation and SNAT3 is mostly expressed in the early period of gestation. It is important to elucidate the route of nutrient supply in the early period of gestation because of its essential role in organogenesis. Taking these findings into consideration, we focused on SNAT3 and hypothesized that it is the main pathway of glutamine supply to the fetus in the early period of gestation.
There are three lines of evidence indicating an important role of SNAT3 in the placenta at the early period of pregnancy. First of all, the concentration of glutamine is higher in fetal blood than in maternal blood, and it must be controlled around 500 µM [24] .
Therefore, it has been suggested that there is an active pathway that transports glutamine to the fetus. This property is well-fitted to SNAT3, which mediates glutamine efflux by low affinity (Km=1.1 mM) and high capacity [17, 36] . Secondly, the environment of fetal blood is matched well with SNAT3 function. SNAT3 is sensitive to pH [37, 38] , and it needs a proton anti-port mechanism to release glutamine [36] . Since the acidity of fetal blood is slightly higher than that of maternal blood [39] , this is the suitable environment for SNAT3.
Finally, results of previous studies and our RT-PCR results show the corresponding alteration of glutamine synthetase with SNAT3 expression. It has been reported that there are two routes to provide glutamine to the fetus: uptake from maternal circulation and production in the placenta [7, 9] . And we examined the characterization of glutamine transport in Bewo cells, cytotrophoblast cell model. The mRNAs of SNAT3 were found to be expressed in Bewo cells Eadie-Hofstee plot analysis showed that glutamine uptake was two-phase uptake (high-affinity phase-0.13mM, low-affinity phase-1.4mM).We suggest that Km value of SNAT3 was similar to that of low affinity phase and SNAT3 transport glutamine in cytotrophoblast cells. In the rat placenta, the activity of glutamine synthetase is greatest on the 12 th day of gestation [40] . This corresponds to our finding that the expression level of SNAT3 in the placenta is the highest in the 11 th day of gestation. In addition to this finding, it was suggested that alterations of human placental SNAT3 and glutamine synthetase correspond with each other. SNAT3 is contributed to provide glutamine, which is produced by glutamine synthetase in cytotrophoblast cells, to fetal circulation [13] .
In the placenta, there is an active glutamate-glutamine cycle to provide glutamine to the fetus and to excrete glutamate and ammonia from fetal circulation [9] . The transporter that mediates glutamine efflux is not known [10, 18] . It is possible that SNAT3 and glutamine synthetase in cytotrophoblast cells are responsible for ammonia metabolism in the early period of pregnancy, supposed at the organogenesis stage.
In conclusion, SNAT3 is expressed in the placenta and it is one of the routes of the supply of glutamine. Little is known about the nutrient transport system through the placenta in the early period of pregnancy. In this study, we found expression of SNAT3 in the early period of gestation or in cytotrophoblast cells. Representative data from 3 different cell isolations of different human term placentas.
*; significantly different throughout the cells differentiation at p<0.05.
